DS

Derek Sloan

AN Affymax Technologies N.V.: 2 patents #36 of 74Top 50%
GS Gilead Sciences: 2 patents #483 of 952Top 55%
GL Glaxo Group Limited: 2 patents #493 of 1,368Top 40%
ID Immune Design: 1 patents #10 of 16Top 65%
Overall (All Time): #702,375 of 4,157,543Top 20%
7
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11597759 Multispecific antibodies that target HIV GP120 and CD3 Tomas Cihlar, Joshua Goldsmith, George Kukolj, Craig S. Pace, Doug Rehder +3 more 2023-03-07
10059697 Compounds and combinations for the treatment of HIV Tomas Cihlar, Michael Graupe, Yunfeng Eric Hu, Jeffrey Patrick Murry, George Stepan +1 more 2018-08-28
8187872 Lentiviral vectors pseudotyped with a sindbis virus envelope glycoprotein James M. Allen, Thomas W. Dubensky, Jr., Jin Zhong Li, Neal Van Hoeven 2012-05-29
5683983 Peptides and compounds that bind to the IL-5 receptor Ronald W. Barrett, Bruce England, Peter J. Schatz, Min-Jia Chen 1997-11-04
5677280 Peptides and compounds that bind to the IL-5 receptor Ronald W. Barrett, Bruce England, Peter J. Schatz, Min-Jia Chen 1997-10-14
5668110 Peptides and compounds that bind to the IL-5 receptor Ronald W. Barrett, Bruce England, Peter J. Schatz, Min-Jia Chen 1997-09-16
5654276 Peptides and compounds that bind to the IL-5 receptor Ronald W. Barrett, Bruce England, Peter J. Schatz, Min-Jia Chen 1997-08-05